Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lokelma versus standard of care for hyperkalemia management in non-dialysis CKD patients with heart failure history
2020-003229-47Phase 3Active
- Sponsor
- INCLIVA Biomedical Research Institute
- Start
- Dec 2021
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hyperkalemia comparing Lokelma arm with Standard of care arm (2 arms). Started Dec 2021; status: active.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on 2020-003229-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003229-47.